Remove 2003 Remove Communication Remove Diabetes
article thumbnail

OPDP Issues First Regulatory Action Letter of 2022

Eye on FDA

According to the letter, the agency noted first of all that the video that was part of the Instagram post stated that Trulicity could “lower A1C along with diet and exercise” but that the Medication Guide specifically states that the drug is used for people with type 2 diabetes. So why did OPDP act upon this Instagram post?

article thumbnail

How clinical pharmacists can save lives and employer costs

HealthPartners

As part of the 2003 Medicare Prescription Drug, Improvement, and Modernization Act, medication therapy management (MTM) is offered to those with Medicare Part D prescription drug plans. A coordinated communication plan then swings into action to guide them to MTM services that help prevent problems from developing or getting worse.

article thumbnail

A history of Johnson & Johnson

pharmaphorum

The company has also faced claims that it did not adequately communicate the risks of its opioid painkillers in its marketing, contributing to the US’ ‘opioid epidemic’, and that its talc products could contain small amounts of asbestos and lead to cancer. Litigation & controversy. Acquisitions post-Janssen.

Vaccines 126